<VariationArchive VariationID="690360" VariationName="NM_000492.4(CFTR):c.2908+1085_3367+260del" VariationType="Deletion" Accession="VCV000690360" Version="2" RecordType="classified" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2024-07-29" DateCreated="2019-09-23" MostRecentSubmission="2019-09-23">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="621888" VariationID="690360">
      <GeneList>
        <Gene Symbol="LOC111674472" FullName="DNase I hypersensitive sites in introns 16 and 17a of CFTR" GeneID="111674472" Source="calculated" RelationshipType="genes overlapped by variant">
          <Location>
            <CytogeneticLocation>7q31.2</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="7" Accession="NC_000007.14" start="117607047" stop="117612650" display_start="117607047" display_stop="117612650" Strand="+" />
          </Location>
        </Gene>
        <Gene Symbol="CFTR" FullName="CF transmembrane conductance regulator" GeneID="1080" HGNC_ID="HGNC:1884" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>7q31.2</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="7" Accession="NC_000007.14" start="117480025" stop="117668665" display_start="117480025" display_stop="117668665" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="7" Accession="NC_000007.13" start="117120016" stop="117308718" display_start="117120016" display_stop="117308718" Strand="+" />
          </Location>
          <OMIM>602421</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_000492.4(CFTR):c.2908+1085_3367+260del</Name>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>7q31.2</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="7" Accession="NC_000007.14" start="117604867" stop="117612068" display_start="117604867" display_stop="117612068" variantLength="7202" positionVCF="117604866" referenceAlleleVCF="AGAAGAGTCAGACATGAGCGATGAGGCACAGTGGAAAGAACATGAGCATTGCCTGAGCTCTGAGTTGGCGCTATAAGAGCAGTGATCATGGGCAAGTGACTCTTCTGAGCCTTGGCCTCCTCACCTGTTAAGTGAAGAAAAGAATATTTCAGAAGATCTTTGTGAGAATGAAACAAGGCAATTTACTTGCCTGCTACATAGCCAATGGGAAATCAATATAAGTTCCCCGTGGTTCCCTTCTGTGGGGTTTTGTTCCCACAGAGGGTGCACTGGCCATTCCACTTCTTCTTTTCCAAGCTCCTCATTCCCTTTAACGCTGTTCATAGTTGGTTCCAAACCATTTGAAATATAATAAGCACCAGGATGGTTTTTTCTTTCCACCAAAGCAAATTTCATTTTCTAAACACTGTTTATAAATATCAATGGCTATTTTTTCAATTTTTGATTATCATGAAAATATACAAATATGTTTAATTAAATATGCTAAAGAATGTATTAATAAATATGTATTAAATAATTCCTACATATAAGGCCTTTTTGCTTGGGGTATGGGTGATACAAAATAAATGTGGCATGAACCCACTGACCTCTAGCAATTTATAACCTAGAAAAAGAGTTATGATATGTTTATAAGTTCCTGTGATATAAGACATGCATATAGTCATTATAACAGAGGTGCAAACAAGATGTATCAAGTATGTCCAGAGGAGGAAGAGATTAATCCCAGCTGGAGGAAACACTGATGCTTTCTTGCAGCAGGGGCATTTGAGTTGAGAAAGGGAGGAAACATAGATTTTGACAATGAGAGCTGAGGGGAAAGGGGTTTCAGGTGGAGGGAACCGCATGTGGAAAGCAGGGAGGTAGGAAAGTGTAGAGTGTGTTTAAAGAATAGACCAGTTTGGCTGAAACAGGATATTTGAGCAGAGGAAGCTTGTACTAGGTAGGTGGGTTGAGGCCAAATTATGCAAGGCATTAAATATTAAACTAGGAATTTTGGACTTTATCCTGCAGTTTATGGGGGGTAAATGATAAGATTCAATATCACTTTATTTGTACAGTATTATGTTACATTTTATCTAATTGTTTGTTTAATTCCTGTCTAGACAATGAATTCCTCAAGGGCAAGGAGCATGGCTTATTCACCTCAGTAATTTCAGTGCCTAGCATTGTGCCTGGTACAAAGTGGACACTTGTATATAACCTTTTTTAATTGAAGCAACAAGTTGTCAACCTTACAAATGTGAATCCGTGATTCAGATGACAGGTTGAAATGTAGATTGTCTGCGAAGAGGGCAGAAAGAGAGTATGACAAAGGAGGACAAGACAGTGGGGCAGGCAGGGAGAGAGAGCAGCCAGGGTTTCGGTAGAGGTATGTCAAAAAGGTATGGAAGTCAGAGGAGAAGGAGACCCCTATGTTATAGAATACAAATGGAAGGGAAATGATGACAACAGTAAGTTGTCATTAAATGCAAGGTTGCAAAAGTAAGATTGTAAAGCAGGATGAGTACCCACCTATTCCTGACATAATTTATAGTAAAAGCTATTTCAGAGAAATTGGTCGTTACTTGAATCTTACAAGAATCTGAAACTTTTAAAAAGGTTTAAAAGTAAAAGACAATAACTTGAACACATAATTATTTAGAATGTTTGGAAAGAAACAAAAATTTCTAAGTCTATCTGATTCTATTTGCTAATTCTTATTTGGGTTCTGAATGCGTCTACTGTGATCCAAACTTAGTATTGAATATATTGATATATCTTTAAAAAATTAGTGTTTTTTGAGGAATTTGTCATCTTGTATATTATAGGTGGGATTCTTAATAGATTCTCCAAAGATATAGCAATTTTGGATGACCTTCTGCCTCTTACCATATTTGACTTCATCCAGGTATGTAAAAATAAGTACCGTTAAGTATGTCTGTATTATTAAAAAAACAATAACAAAAGCAAATGTGATTTTGTTTTCATTTTTTATTTGATTGAGGGTTGAAGTCCTGTCTATTGCATTAATTTTGTAATTATCCAAAGCCTTCAAAATAGACATAAGTTTAGTAAATTCAATAATAAGTCAGAACTGCTTACCTGGCCCAAACCTGAGGCAATCCCACATTTAGATGTAATAGCTGTCTACTTGGGAGTGATTTGAGAGGCACAAAGGACCATCTTTCCCAAAATCACTGGCCACAAAGTGTGACATTTTGGCATTGGCATCACTATTTGATGGAAGCCAACCTCCCCCCAAAAGGCCTGTATTAGAATGAAGATGGATTCCCTGGGTGGGTTACACTTGAAACTAGCCTCACCCATGAACACTTTGGCACAGATTAGCTAGCCCATTCCCCCACAGTAAGGACCATAAGGAAGGGACAGAAGCAAAGATAAGTTTTAGAACAAAAGAGAGGGGAAAGAAAAAATCTAGGGTTTTATGAGGGCTGTCCCTGAGTGATAGATGTGAATAGGCCTCCAGGGCAGGCTGGCTCAGAGGCTGACTCTTTGGGTTGGGGTGACTGATTGGTGGTGAGGATGGAGAAGAAAAGGGGAGTGGAGGAGGTGAAAGTGACCTTGGGACATTAGGTCTCCATAAGTGACAGGATTTAAGGAGTGTTGTAAGCTGTGGTTGTTGGACCAGGTTTAAGCACAGCTTCCTGAGCTTCCTGACTGGTTTAGGTCAAGCTCCAGAGAGCAAATGCCACAGTCTCAGTGATCTCCTTGGAGAAACAGTTGGAATAGGATGTTGCCCATGTTGGGATGAGTCATTGTCCGCTCTTGCTCTTTCCCTACCCCTGCAAAATAATAATACTGTATTTGATTGAACATATAAAACAAAAGAAGGATTATCACATAAGTATGTATATATAACCAACATTGGCAGGTGCAGAAAAACCAGACTGTCAGTTTGCCTCATCTGAAATGATTGACACAAACAAATATATTTACTGTCCCAAGTGAACTTTGGCATTTTGGATATCCTTCAGTTGTTCTGTTTAAAGATATAACTTAGAAGCAGCTGATGGAATATTTAAATCCATGCGTTGAATTCATGCATTCAAAGAAACATGTCCTGAGTCACTAAATGCTGACATTTGTTTTTCATGTTAAGAGTGTAAATAACTGGTCCCAAATATAATATTATTACATCAGATAAAAACTGGAATGTGAACCTCTTAACTTGATTGTGAAAGTATTTGCCAATGGTGCCTCTTGATAATTATTTGAGGCTCACTTCAGAACTCCTCTGGAAGGGTTAATTTTTAAATAGTCATTTTATAAATTAACATTTTTGACATATGTGATGGCTCTCAAATTTTTTCTTTTATGCCAGTTTGAATCATTTCTGCTCAATTTTTTTTTTTAATTGGGATGGAGTCTCACTCTGTTGCCCAGGCTGGAGTGCAGTGATGCAATCTTGGCTGACTGCAACCTCCACCTCCTCGGTTCAAGCGATTCTCTCGCATCAGCCTCCAGAGTAGCTGGGATTACAGGCGCGCACCACCATGCCTGGATAATTTTTGTATTATTACTAGAGATGGGGTTTCACCACGTTGGCCAGGCTGGTCTTGAACTCCTGAACTCCTGACCTCAAGTGATCCACCTGCCTCAGCCTCTTAAAGAGCTGGAATTATAGGTGTGAGCCACTGCACCAGGCCCTGTTCAACTTTTAATGCTAAGATTCATTTGTTGTTGTTTCACAAGTGATTAGGCAGAGGTCTTTTATATTAATTTACCCATTTTATTTGTAAGAGAGTCTCATATTAAGGAAGCATAATATATGACAATCCAAATACAGTACAAATTTGGTTAATTTTGATTTTGTTAAATAATTAATCACAGGGGTCCTTCAAATTGTGAGCTCCTCTGGTTATACTTATGTTTTACCTCTGGTTATACTTAATTTCAAACAAATGAAATTTCATTCTATTCATGATATTTCAGAAGCAGATCTGTTGCACAAAATAAAGCATACCTATAAATTTTCTTTTTTTAAAAAAAAGTCTCTGTTCACTCTATTTTCTATTATTTTTCTCTTTTTAAAATTTGAATTTTATTGTGGCAAGTCCACTTAACATGAGATTTACCCTCTTAACAGATTTTTATGTGTAAAATACAATATTGTTCACCATGGGTAAATGTTGCACAGCAGATCTCTGGAACTTATTCATTTTGCACTACTGAAATTTTATACCTGTTGATTAGTATCTCCCCATTTCCCTCTCTCCCCTGTCCTGTTACCCATGGTTCTGTTCTTTGCTTCTTTGAGTTTGAGTATTTTGATACCTCATGTAATCTTCATTCTATTTTCTAACTTTGACAATGTTCTGACAAATTTGCTTTCCGGATTGGAGCACTGTATAGTGAAAATTGAAAATCTTGGTTATTTTCTACAGATTCCCACTATTTTACCTTGAGCAGACACTTATCTTGAAGGGTCTCAGATTTGTCACTTGTAGAATGGGGAATATAAACCTGATAATGGTCCCTTTCAGTTCTAAAGTTATATCAGTTGAAAATACATGTGTCACTTATGGTAACGGGTAGAGAACTGGCTCACTGAACAGCATATGGATATTATAAAGTGGTTTTTTTTAATCCTTTCTGCAGACAGTTACTTTATACTTTATTCAAATGGATTATTGTGAAGTACATGTTAGCGGACTTTGTACCTTTTAAAAATGTATGTATTTGGTGTAATGTAGAAATATAGAAATTTATTAAGTATGATTTATTTCAATGTTAAGCATGAGAAAATATGCTCCGAAAGGTTAGATAGCTTGCCTAAATGACAAGCTTGTATTTCAAGCAGAACTTTCTGAATCAAAAGACTCCAAGACGAATGCCCAGCTTTCAAAAACTGTCTAACCAAAATAAATCCTAAGATTCACCTTCATACTAAAATTATTTAAAAATAGTTTATTTTAAATTAATATTCACTTAAAATGTATTTATCATGCAATACTTTAAAGTGTCTGGGAAATGAAAATATCCAAAGATCAAAGAACACCATGTTTTCAAACTTCAAAAATGTTATCAGTGACCTAAACAATTTTTAAAATTTTCATAGAGCCTATGAAAAATGTACTTGCAAATGGCTACTTTCTGACTAGGAATAGAATGGGGAGAGTATTTAGTCCAACAATGATAGACTGGATTAAGAAAATGTGGCACATATACACCATGGAACACTATGCAGCCATAAAAAATGATGAGTTCATGTCCTTTGTAGGGACATGGATGAAATTGGAAAACATCATTCTCAGTAAACTATCGCAAGAACAAAAAACCAAACACCGCATATTCTCACTCATAGGTGGGAATTGAACAATGAGATCACATGGACACAGGAAGGGGAATATCACACTCTGGGGACTGTTGTGGGGTGGGGGGAGGGGGGAGGGATAGCACTGGGAGATATACCTAATGCTAGATGACGAGTTAGTGGGTGCAGTGCACCAGCATGGCACATGTATACATATGTAACTAACCTGCACAATGTGCACATGTACCCTAAAACTTAAAGTATAATAAAAAAAATAAAAAAAAGTTTGAGGTGTTTAAAGTATGCAAAAAAAAAAAAAGAAATAAATCACTGACACACTTTGTCCACTTTGCAATGTGAAAATGTTTACTCACCAACATGTTTTCTTTGATCTTACAGTTGTTATTAATTGTGATTGGAGCTATAGCAGTTGTCGCAGTTTTACAACCCTACATCTTTGTTGCAACAGTGCCAGTGATAGTGGCTTTTATTATGTTGAGAGCATATTTCCTCCAAACCTCACAGCAACTCAAACAACTGGAATCTGAAGGTATGACAGTGAATGTGCGATACTCATCTTGTAAAAAAGCTATAAGAGCTATTTGAGATTCTTTATTGTTAATCTACTTAAAAAAAATTCTGCTTTTAAACTTTTACATCATATAACAATAATTTTTTTCTACATGCATGTGTATATAAAAGGAAACTATATTACAAAGTACACATGGATTTTTTTTCTTAATTAATGACCATGTGACTTCATTTTGGTTTTAAAATAGGTATATAGAATCTTACCACAGTTGGTGTACAGGACATTCATTTATAATAAACTTATATCAGTCAAATTAAACAAGGATAGTGCTGCTATTACTAAAGGTTTCTCTGGGTTCCCAAATGATACTTGACCAAATTTGTCCCTTTGGCTTGTTGTCTTCAGACACCCTTTCTTCATGTGTTGGAGCTGCCATTTCGTGTGCCCCCAAACTCTACTTGAGCTGTTAGGGAATCACATTTTGCAGTGACAGCCTTAGTGTGGGTGCATTTTCAGGCAATACTTTTTCAGTATATTTCTGCTTTGTAGATTATTAGCTAAATCAAGTCACATAAACTTCCTTAATTTAGATACTTGAAAAAATTGTCTTAAAAGAAAATTTTTTTAGTAAGAATTAATTTAGAATTAGCCAGAAAACTCCCAGTGGTAGCCAAGAAAGAGGAATAAATATTGGTGGTAATTTTTTAAGTTCCCATCTCTGGTAGCCAAGTAAAAAAAGAGGGTAACTCATTAATAAAATAACAAATCATATCTATTCAAAGAATGGCACCAGTGTGAAAAAAAGCTTTTTAACCAATGACATTTGTGATATGATTATTCTAATTTAGTCTTTTTCAGGTACAAGATATTATGAAATTACATTTTGTGTTTATGTTATTTGCAATGTTTTCTATGGAAATATTTCACAGGCAGGAGTCCAATTTTCACTCATCTTGTTACAAGCTTAAAAGGACTATGGACACTTCGTGCCTTCGGACGGCAGCCTTACTTTGAAACTCTGTTCCACAAAGCTCTGAATTTACATACTGCCAACTGGTTCTTGTACCTGTCAACACTGCGCTGGTTCCAAATGAGAATAGAAATGATTTTTGTCATCTTCTTCATTGCTGTTACCTTCATTTCCATTTTAACAACAGGTACTATGAACTCATTAACTTTAGCTAAGCATTTAAGTAAAAAATTTTCAATGAATAAAATGCTGCATTCTATAGGTTATCAATTTTTGATATCTTTAGAGTTTAGTAATTAACAAATTTGTTGGTTTATTATTGAACAAGTGATTTCTTTGAATTTCCATTGTTTTATTGTTAAACAAATAATTTCCTTGAAATCGGATATATATATATATATGTATATATATATATATATATATATATATATACATATATATATATAG" alternateAlleleVCF="A" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="7" Accession="NC_000007.13" start="117244921" stop="117252122" display_start="117244921" display_stop="117252122" variantLength="7202" positionVCF="117244920" referenceAlleleVCF="AGAAGAGTCAGACATGAGCGATGAGGCACAGTGGAAAGAACATGAGCATTGCCTGAGCTCTGAGTTGGCGCTATAAGAGCAGTGATCATGGGCAAGTGACTCTTCTGAGCCTTGGCCTCCTCACCTGTTAAGTGAAGAAAAGAATATTTCAGAAGATCTTTGTGAGAATGAAACAAGGCAATTTACTTGCCTGCTACATAGCCAATGGGAAATCAATATAAGTTCCCCGTGGTTCCCTTCTGTGGGGTTTTGTTCCCACAGAGGGTGCACTGGCCATTCCACTTCTTCTTTTCCAAGCTCCTCATTCCCTTTAACGCTGTTCATAGTTGGTTCCAAACCATTTGAAATATAATAAGCACCAGGATGGTTTTTTCTTTCCACCAAAGCAAATTTCATTTTCTAAACACTGTTTATAAATATCAATGGCTATTTTTTCAATTTTTGATTATCATGAAAATATACAAATATGTTTAATTAAATATGCTAAAGAATGTATTAATAAATATGTATTAAATAATTCCTACATATAAGGCCTTTTTGCTTGGGGTATGGGTGATACAAAATAAATGTGGCATGAACCCACTGACCTCTAGCAATTTATAACCTAGAAAAAGAGTTATGATATGTTTATAAGTTCCTGTGATATAAGACATGCATATAGTCATTATAACAGAGGTGCAAACAAGATGTATCAAGTATGTCCAGAGGAGGAAGAGATTAATCCCAGCTGGAGGAAACACTGATGCTTTCTTGCAGCAGGGGCATTTGAGTTGAGAAAGGGAGGAAACATAGATTTTGACAATGAGAGCTGAGGGGAAAGGGGTTTCAGGTGGAGGGAACCGCATGTGGAAAGCAGGGAGGTAGGAAAGTGTAGAGTGTGTTTAAAGAATAGACCAGTTTGGCTGAAACAGGATATTTGAGCAGAGGAAGCTTGTACTAGGTAGGTGGGTTGAGGCCAAATTATGCAAGGCATTAAATATTAAACTAGGAATTTTGGACTTTATCCTGCAGTTTATGGGGGGTAAATGATAAGATTCAATATCACTTTATTTGTACAGTATTATGTTACATTTTATCTAATTGTTTGTTTAATTCCTGTCTAGACAATGAATTCCTCAAGGGCAAGGAGCATGGCTTATTCACCTCAGTAATTTCAGTGCCTAGCATTGTGCCTGGTACAAAGTGGACACTTGTATATAACCTTTTTTAATTGAAGCAACAAGTTGTCAACCTTACAAATGTGAATCCGTGATTCAGATGACAGGTTGAAATGTAGATTGTCTGCGAAGAGGGCAGAAAGAGAGTATGACAAAGGAGGACAAGACAGTGGGGCAGGCAGGGAGAGAGAGCAGCCAGGGTTTCGGTAGAGGTATGTCAAAAAGGTATGGAAGTCAGAGGAGAAGGAGACCCCTATGTTATAGAATACAAATGGAAGGGAAATGATGACAACAGTAAGTTGTCATTAAATGCAAGGTTGCAAAAGTAAGATTGTAAAGCAGGATGAGTACCCACCTATTCCTGACATAATTTATAGTAAAAGCTATTTCAGAGAAATTGGTCGTTACTTGAATCTTACAAGAATCTGAAACTTTTAAAAAGGTTTAAAAGTAAAAGACAATAACTTGAACACATAATTATTTAGAATGTTTGGAAAGAAACAAAAATTTCTAAGTCTATCTGATTCTATTTGCTAATTCTTATTTGGGTTCTGAATGCGTCTACTGTGATCCAAACTTAGTATTGAATATATTGATATATCTTTAAAAAATTAGTGTTTTTTGAGGAATTTGTCATCTTGTATATTATAGGTGGGATTCTTAATAGATTCTCCAAAGATATAGCAATTTTGGATGACCTTCTGCCTCTTACCATATTTGACTTCATCCAGGTATGTAAAAATAAGTACCGTTAAGTATGTCTGTATTATTAAAAAAACAATAACAAAAGCAAATGTGATTTTGTTTTCATTTTTTATTTGATTGAGGGTTGAAGTCCTGTCTATTGCATTAATTTTGTAATTATCCAAAGCCTTCAAAATAGACATAAGTTTAGTAAATTCAATAATAAGTCAGAACTGCTTACCTGGCCCAAACCTGAGGCAATCCCACATTTAGATGTAATAGCTGTCTACTTGGGAGTGATTTGAGAGGCACAAAGGACCATCTTTCCCAAAATCACTGGCCACAAAGTGTGACATTTTGGCATTGGCATCACTATTTGATGGAAGCCAACCTCCCCCCAAAAGGCCTGTATTAGAATGAAGATGGATTCCCTGGGTGGGTTACACTTGAAACTAGCCTCACCCATGAACACTTTGGCACAGATTAGCTAGCCCATTCCCCCACAGTAAGGACCATAAGGAAGGGACAGAAGCAAAGATAAGTTTTAGAACAAAAGAGAGGGGAAAGAAAAAATCTAGGGTTTTATGAGGGCTGTCCCTGAGTGATAGATGTGAATAGGCCTCCAGGGCAGGCTGGCTCAGAGGCTGACTCTTTGGGTTGGGGTGACTGATTGGTGGTGAGGATGGAGAAGAAAAGGGGAGTGGAGGAGGTGAAAGTGACCTTGGGACATTAGGTCTCCATAAGTGACAGGATTTAAGGAGTGTTGTAAGCTGTGGTTGTTGGACCAGGTTTAAGCACAGCTTCCTGAGCTTCCTGACTGGTTTAGGTCAAGCTCCAGAGAGCAAATGCCACAGTCTCAGTGATCTCCTTGGAGAAACAGTTGGAATAGGATGTTGCCCATGTTGGGATGAGTCATTGTCCGCTCTTGCTCTTTCCCTACCCCTGCAAAATAATAATACTGTATTTGATTGAACATATAAAACAAAAGAAGGATTATCACATAAGTATGTATATATAACCAACATTGGCAGGTGCAGAAAAACCAGACTGTCAGTTTGCCTCATCTGAAATGATTGACACAAACAAATATATTTACTGTCCCAAGTGAACTTTGGCATTTTGGATATCCTTCAGTTGTTCTGTTTAAAGATATAACTTAGAAGCAGCTGATGGAATATTTAAATCCATGCGTTGAATTCATGCATTCAAAGAAACATGTCCTGAGTCACTAAATGCTGACATTTGTTTTTCATGTTAAGAGTGTAAATAACTGGTCCCAAATATAATATTATTACATCAGATAAAAACTGGAATGTGAACCTCTTAACTTGATTGTGAAAGTATTTGCCAATGGTGCCTCTTGATAATTATTTGAGGCTCACTTCAGAACTCCTCTGGAAGGGTTAATTTTTAAATAGTCATTTTATAAATTAACATTTTTGACATATGTGATGGCTCTCAAATTTTTTCTTTTATGCCAGTTTGAATCATTTCTGCTCAATTTTTTTTTTTAATTGGGATGGAGTCTCACTCTGTTGCCCAGGCTGGAGTGCAGTGATGCAATCTTGGCTGACTGCAACCTCCACCTCCTCGGTTCAAGCGATTCTCTCGCATCAGCCTCCAGAGTAGCTGGGATTACAGGCGCGCACCACCATGCCTGGATAATTTTTGTATTATTACTAGAGATGGGGTTTCACCACGTTGGCCAGGCTGGTCTTGAACTCCTGAACTCCTGACCTCAAGTGATCCACCTGCCTCAGCCTCTTAAAGAGCTGGAATTATAGGTGTGAGCCACTGCACCAGGCCCTGTTCAACTTTTAATGCTAAGATTCATTTGTTGTTGTTTCACAAGTGATTAGGCAGAGGTCTTTTATATTAATTTACCCATTTTATTTGTAAGAGAGTCTCATATTAAGGAAGCATAATATATGACAATCCAAATACAGTACAAATTTGGTTAATTTTGATTTTGTTAAATAATTAATCACAGGGGTCCTTCAAATTGTGAGCTCCTCTGGTTATACTTATGTTTTACCTCTGGTTATACTTAATTTCAAACAAATGAAATTTCATTCTATTCATGATATTTCAGAAGCAGATCTGTTGCACAAAATAAAGCATACCTATAAATTTTCTTTTTTTAAAAAAAAGTCTCTGTTCACTCTATTTTCTATTATTTTTCTCTTTTTAAAATTTGAATTTTATTGTGGCAAGTCCACTTAACATGAGATTTACCCTCTTAACAGATTTTTATGTGTAAAATACAATATTGTTCACCATGGGTAAATGTTGCACAGCAGATCTCTGGAACTTATTCATTTTGCACTACTGAAATTTTATACCTGTTGATTAGTATCTCCCCATTTCCCTCTCTCCCCTGTCCTGTTACCCATGGTTCTGTTCTTTGCTTCTTTGAGTTTGAGTATTTTGATACCTCATGTAATCTTCATTCTATTTTCTAACTTTGACAATGTTCTGACAAATTTGCTTTCCGGATTGGAGCACTGTATAGTGAAAATTGAAAATCTTGGTTATTTTCTACAGATTCCCACTATTTTACCTTGAGCAGACACTTATCTTGAAGGGTCTCAGATTTGTCACTTGTAGAATGGGGAATATAAACCTGATAATGGTCCCTTTCAGTTCTAAAGTTATATCAGTTGAAAATACATGTGTCACTTATGGTAACGGGTAGAGAACTGGCTCACTGAACAGCATATGGATATTATAAAGTGGTTTTTTTTAATCCTTTCTGCAGACAGTTACTTTATACTTTATTCAAATGGATTATTGTGAAGTACATGTTAGCGGACTTTGTACCTTTTAAAAATGTATGTATTTGGTGTAATGTAGAAATATAGAAATTTATTAAGTATGATTTATTTCAATGTTAAGCATGAGAAAATATGCTCCGAAAGGTTAGATAGCTTGCCTAAATGACAAGCTTGTATTTCAAGCAGAACTTTCTGAATCAAAAGACTCCAAGACGAATGCCCAGCTTTCAAAAACTGTCTAACCAAAATAAATCCTAAGATTCACCTTCATACTAAAATTATTTAAAAATAGTTTATTTTAAATTAATATTCACTTAAAATGTATTTATCATGCAATACTTTAAAGTGTCTGGGAAATGAAAATATCCAAAGATCAAAGAACACCATGTTTTCAAACTTCAAAAATGTTATCAGTGACCTAAACAATTTTTAAAATTTTCATAGAGCCTATGAAAAATGTACTTGCAAATGGCTACTTTCTGACTAGGAATAGAATGGGGAGAGTATTTAGTCCAACAATGATAGACTGGATTAAGAAAATGTGGCACATATACACCATGGAACACTATGCAGCCATAAAAAATGATGAGTTCATGTCCTTTGTAGGGACATGGATGAAATTGGAAAACATCATTCTCAGTAAACTATCGCAAGAACAAAAAACCAAACACCGCATATTCTCACTCATAGGTGGGAATTGAACAATGAGATCACATGGACACAGGAAGGGGAATATCACACTCTGGGGACTGTTGTGGGGTGGGGGGAGGGGGGAGGGATAGCACTGGGAGATATACCTAATGCTAGATGACGAGTTAGTGGGTGCAGTGCACCAGCATGGCACATGTATACATATGTAACTAACCTGCACAATGTGCACATGTACCCTAAAACTTAAAGTATAATAAAAAAAATAAAAAAAAGTTTGAGGTGTTTAAAGTATGCAAAAAAAAAAAAAGAAATAAATCACTGACACACTTTGTCCACTTTGCAATGTGAAAATGTTTACTCACCAACATGTTTTCTTTGATCTTACAGTTGTTATTAATTGTGATTGGAGCTATAGCAGTTGTCGCAGTTTTACAACCCTACATCTTTGTTGCAACAGTGCCAGTGATAGTGGCTTTTATTATGTTGAGAGCATATTTCCTCCAAACCTCACAGCAACTCAAACAACTGGAATCTGAAGGTATGACAGTGAATGTGCGATACTCATCTTGTAAAAAAGCTATAAGAGCTATTTGAGATTCTTTATTGTTAATCTACTTAAAAAAAATTCTGCTTTTAAACTTTTACATCATATAACAATAATTTTTTTCTACATGCATGTGTATATAAAAGGAAACTATATTACAAAGTACACATGGATTTTTTTTCTTAATTAATGACCATGTGACTTCATTTTGGTTTTAAAATAGGTATATAGAATCTTACCACAGTTGGTGTACAGGACATTCATTTATAATAAACTTATATCAGTCAAATTAAACAAGGATAGTGCTGCTATTACTAAAGGTTTCTCTGGGTTCCCAAATGATACTTGACCAAATTTGTCCCTTTGGCTTGTTGTCTTCAGACACCCTTTCTTCATGTGTTGGAGCTGCCATTTCGTGTGCCCCCAAACTCTACTTGAGCTGTTAGGGAATCACATTTTGCAGTGACAGCCTTAGTGTGGGTGCATTTTCAGGCAATACTTTTTCAGTATATTTCTGCTTTGTAGATTATTAGCTAAATCAAGTCACATAAACTTCCTTAATTTAGATACTTGAAAAAATTGTCTTAAAAGAAAATTTTTTTAGTAAGAATTAATTTAGAATTAGCCAGAAAACTCCCAGTGGTAGCCAAGAAAGAGGAATAAATATTGGTGGTAATTTTTTAAGTTCCCATCTCTGGTAGCCAAGTAAAAAAAGAGGGTAACTCATTAATAAAATAACAAATCATATCTATTCAAAGAATGGCACCAGTGTGAAAAAAAGCTTTTTAACCAATGACATTTGTGATATGATTATTCTAATTTAGTCTTTTTCAGGTACAAGATATTATGAAATTACATTTTGTGTTTATGTTATTTGCAATGTTTTCTATGGAAATATTTCACAGGCAGGAGTCCAATTTTCACTCATCTTGTTACAAGCTTAAAAGGACTATGGACACTTCGTGCCTTCGGACGGCAGCCTTACTTTGAAACTCTGTTCCACAAAGCTCTGAATTTACATACTGCCAACTGGTTCTTGTACCTGTCAACACTGCGCTGGTTCCAAATGAGAATAGAAATGATTTTTGTCATCTTCTTCATTGCTGTTACCTTCATTTCCATTTTAACAACAGGTACTATGAACTCATTAACTTTAGCTAAGCATTTAAGTAAAAAATTTTCAATGAATAAAATGCTGCATTCTATAGGTTATCAATTTTTGATATCTTTAGAGTTTAGTAATTAACAAATTTGTTGGTTTATTATTGAACAAGTGATTTCTTTGAATTTCCATTGTTTTATTGTTAAACAAATAATTTCCTTGAAATCGGATATATATATATATATGTATATATATATATATATATATATATATATACATATATATATATAG" alternateAlleleVCF="A" />
      </Location>
      <OtherNameList>
        <Name>EX16-17b DEL</Name>
      </OtherNameList>
      <HGVSlist>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_016465.4" sequenceAccession="NG_016465" sequenceVersion="4" change="g.144084_151285del7202">
            <Expression>NG_016465.4:g.144084_151285del7202</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000492.2" sequenceAccession="NM_000492" sequenceVersion="2" change="c.2908+1085_c.3367+260del7201">
            <Expression>NM_000492.2:c.2908+1085_c.3367+260del7201</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000007.13" sequenceAccession="NC_000007" sequenceVersion="13" change="g.117244921_117252122del" Assembly="GRCh37">
            <Expression>NC_000007.13:g.117244921_117252122del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000007.14" sequenceAccession="NC_000007" sequenceVersion="14" change="g.117604867_117612068del" Assembly="GRCh38">
            <Expression>NC_000007.14:g.117604867_117612068del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_016465.4" sequenceAccession="NG_016465" sequenceVersion="4" change="g.144084_151285del">
            <Expression>NG_016465.4:g.144084_151285del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000492.4" sequenceAccession="NM_000492" sequenceVersion="4" change="c.2908+1085_3367+260del" MANESelect="true">
            <Expression>NM_000492.4:c.2908+1085_3367+260del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001574" Type="splice acceptor variant" DB="SO" />
          <MolecularConsequence ID="SO:0001575" Type="splice donor variant" DB="SO" />
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_663" sequenceAccession="LRG_663">
            <Expression>LRG_663:g.144084_151285del</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="Allelic variant" ID="602421.0138" DB="OMIM" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_000492.4(CFTR):c.2908+1085_3367+260del AND Cystic fibrosis" Accession="RCV000851288" Version="9">
        <ClassifiedConditionList TraitSetID="1961">
          <ClassifiedCondition DB="MedGen" ID="C0010674">Cystic fibrosis</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="2007-10-01" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2007-10-01" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2019-09-23" MostRecentSubmission="2019-09-23">
        <ReviewStatus>no assertion criteria provided</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">17850636</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">22572733</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">29951967</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">31136843</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="1961" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="1695" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Mucoviscidosis</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Cystic fibrosis</ElementValue>
                <XRef ID="Cystic+Fibrosis/2071" DB="Genetic Alliance" />
                <XRef ID="MONDO:0009061" DB="MONDO" />
                <XRef Type="MIM" ID="219700" DB="OMIM" />
                <XRef ID="190905008" DB="SNOMED CT" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">CF</ElementValue>
                <XRef Type="MIM" ID="219700" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">Cystic fibrosis (CF) is a multisystem disease affecting epithelia of the respiratory tract, exocrine pancreas, intestine, hepatobiliary system, and exocrine sweat glands. Morbidities include recurrent sinusitis and bronchitis, progressive obstructive pulmonary disease with bronchiectasis, exocrine pancreatic deficiency and malnutrition, pancreatitis, gastrointestinal manifestations (meconium ileus, rectal prolapse, distal intestinal obstructive syndrome), liver disease, diabetes, male infertility due to hypoplasia or aplasia of the vas deferens, and reduced fertility or infertility in some women. Pulmonary disease is the major cause of morbidity and mortality in CF.</Attribute>
                <XRef ID="NBK1250" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="disease mechanism" integerValue="273">loss of function</Attribute>
                <XRef ID="GTR000570054" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000569983" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000528606" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000501921" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000514611" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000005248" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000558928" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000569790" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000556535" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000529460" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000570317" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000592334" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000025280" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000592289" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000569406" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000521905" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000501920" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000507950" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000226639" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000507006" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000592286" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000520059" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000568279" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000508889" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000508812" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000569602" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000028916" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000004176" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000592287" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000556536" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000570010" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000530118" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000328569" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000591289" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000332363" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000570019" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000246717" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000592960" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000558875" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000569639" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000277984" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000592290" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000508894" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000209428" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000571198" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000576178" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000569946" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000320929" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000569960" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000501918" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000508810" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000569426" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000501120" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000507003" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000508811" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000569791" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000508893" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000074114" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000522527" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000569982" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000508890" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000508782" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000330969" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000507864" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000507010" DB="Genetic Testing Registry (GTR)" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="6233" />
                <XRef ID="6233" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="general" Abbrev="ACMG/ACOG, 2001">
                <ID Source="PubMed">11280952</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG, 2004">
                <ID Source="pmc">3110945</ID>
              </Citation>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301428</ID>
                <ID Source="BookShelf">NBK1250</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG, 2008">
                <ID Source="PubMed">18197057</ID>
                <ID Source="pmc">3110977</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACOG, 2009">
                <ID Source="PubMed">19888064</ID>
              </Citation>
              <Citation Type="general" Abbrev="NSGC, 2005">
                <ID Source="PubMed">15789152</ID>
              </Citation>
              <Citation Type="general" Abbrev="CPGPT/CF FPT Committees, 2010">
                <ID Source="PubMed">20675678</ID>
              </Citation>
              <Citation Type="general" Abbrev="ECFS, 2010">
                <ID Source="PubMed">20605539</ID>
              </Citation>
              <Citation Type="general" Abbrev="CFF, 2009">
                <ID Source="PubMed">19914445</ID>
              </Citation>
              <Citation Type="general" Abbrev="CFF, 2009">
                <ID Source="PubMed">19914443</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG ACT Sheets, 2010">
                <ID Source="PubMed">21938795</ID>
              </Citation>
              <Citation Type="practice guideline" Abbrev="DailyMed Drug Label, 2022">
                <URL>https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=0ab0c9f8-3eee-4e0f-9f3f-c1e16aaffe25</URL>
                <CitationText>DailyMed Drug Label, KALYDECO- ivacaftor tablet, 2022</CitationText>
              </Citation>
              <Citation Type="general" Abbrev="ACMG Lab QA, 2002">
                <ID Source="PubMed">12394352</ID>
              </Citation>
              <Citation Type="general" Abbrev="CDC, 2012">
                <ID Source="PubMed">22475884</ID>
              </Citation>
              <Citation Type="Suggested Reading" Abbrev="Accurso et al., 2010">
                <ID Source="pmc">3148255</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACOG, 2011">
                <ID Source="PubMed">21422883</ID>
              </Citation>
              <Citation Type="general" Abbrev="CPIC, 2014">
                <ID Source="PubMed">24598717</ID>
                <ID Source="pmc">4026598</ID>
              </Citation>
              <Citation Type="general" Abbrev="NSGC, 2014">
                <ID Source="PubMed">24014130</ID>
              </Citation>
              <Citation Type="general" Abbrev="HGS Australasia, 2014">
                <ID Source="PubMed">25431289</ID>
              </Citation>
              <Citation Type="Suggested Reading" Abbrev="Wainwright et al., 2015">
                <ID Source="PubMed">25981758</ID>
              </Citation>
              <Citation Type="general" Abbrev="CFF, 2007">
                <ID Source="PubMed">17761616</ID>
              </Citation>
              <Citation Type="general" Abbrev="ECFS, 2018">
                <ID Source="PubMed">29506920</ID>
              </Citation>
              <Citation Type="practice guideline" Abbrev="ACMG ACT, 2011">
                <URL>http://www.acmg.net/ACMG/UploadedPDFS/PDFDocuments/Carrier-Screening-ACT-SheetAshkenazi-Jewish-Genetic-Disorders.aspx</URL>
                <CitationText>American College of Medical Genetics ACT Sheet, Carrier Screening ACT Sheet Ashkenazi Jewish Genetic Disorders</CitationText>
              </Citation>
              <Citation Type="general" Abbrev="ACMG, 2020">
                <ID Source="PubMed">32404922</ID>
                <ID Source="pmc">8268680</ID>
              </Citation>
              <Citation Type="practice guideline" Abbrev="ACMG ACT, 2012">
                <URL>https://www.acmg.net/PDFLibrary/Cystic-Fibrosis-ACT-Sheet.pdf</URL>
                <CitationText>American College of Medical Genetics and Genomics, Newborn Screening ACT Sheet, Elevated IRT +/- DNA, Cystic Fibrosis, 2012</CitationText>
              </Citation>
              <Citation Type="practice guideline" Abbrev="ACMG Algorithm, 2006">
                <URL>https://www.acmg.net/PDFLibrary/IRT_Algorithm.pdf</URL>
                <CitationText>American College of Medical Genetics and Genomics, Algorithm, Immunoreactive Trypsinogen (IRT Elevated), 2006</CitationText>
              </Citation>
              <Citation Type="practice guideline" Abbrev="ACMG ACT, 2012">
                <URL>https://www.acmg.net/PDFLibrary/CF-Mutation-not-R117H.pdf</URL>
                <CitationText>American College of Medical Genetics and Genomics Carrier Screening ACT Sheet, CFTR Mutations except R117H, Cystic Fibrosis (CF), 2012</CitationText>
              </Citation>
              <Citation Type="practice guideline" Abbrev="ACMG ACT, 2012">
                <URL>https://www.acmg.net/PDFLibrary/CF-Mutation-R117H.pdf</URL>
                <CitationText>American College of Medical Genetics and Genomics Carrier Screening ACT Sheet, Cystic Fibrosis R117H, 2012</CitationText>
              </Citation>
              <Citation Type="practice guideline" Abbrev="ACMG ACT, 2012">
                <URL>https://www.acmg.net/PDFLibrary/CF-No-Mutation.pdf</URL>
                <CitationText>American College of Medical Genetics and Genomics Carrier Screening ACT Sheet, No Mutations Detected by Carrier Screening, Cystic Fibrosis (CF), 2012</CitationText>
              </Citation>
              <XRef ID="586" DB="Orphanet" />
              <XRef ID="C0010674" DB="MedGen" />
              <XRef ID="MONDO:0009061" DB="MONDO" />
              <XRef Type="MIM" ID="219700" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="1948046" SubmissionDate="2019-09-20" DateLastUpdated="2019-09-23" DateCreated="2019-09-23">
        <ClinVarSubmissionID localKey="602421.0138_CYSTIC FIBROSIS" title="CFTR, EX16-17b DEL_CYSTIC FIBROSIS" />
        <ClinVarAccession Accession="SCV000993542" DateUpdated="2019-09-23" DateCreated="2019-09-23" Type="SCV" Version="1" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2007-10-01">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">Girardet et al. (2007) reported a male neonate with cystic fibrosis (CF; 219700) who was compound heterozygous for 2 large CFTR rearrangements, one a deletion involving exon 2 inherited from his Sicilian father, and the other a deletion removing exons 16, 17a, and 17b (c.2908+1085_c.3367+260del7201, NM_000492.2) inherited from his South Korean mother. The deletion extended from intron 15 to intron 17b of the gene. Numbering of this mutation uses A of the ATG start codon as the +1 position.</Attribute>
              <Citation>
                <ID Source="PubMed">17850636</ID>
              </Citation>
              <XRef DB="OMIM" ID="219700" Type="MIM" />
            </ObservedData>
            <ObservedData>
              <Attribute Type="Description">In a Japanese boy diagnosed with CF on the basis of chronic respiratory infection and elevated sweat chloride levels, in whom no mutation had been identified by conventional analysis, Nakakuki et al. (2012) detected the 7.2-kb deletion identified by Girardet et al. (2007) using direct sequencing. A splicing defect was found on the other allele. Nakakuki et al. (2012) predicted that the mutated protein would lack amino acids 970 through 1122, which correspond to transmembrane regions 9, 10, and 11.</Attribute>
              <Citation>
                <ID Source="PubMed">22572733</ID>
              </Citation>
              <Citation>
                <ID Source="PubMed">17850636</ID>
              </Citation>
            </ObservedData>
            <ObservedData>
              <Attribute Type="Description">Sohn et al. (2019) performed a clinical characterization and genetic analysis of CFTR in 6 Korean patients from 5 families with cystic fibrosis. Six of the 12 alleles (50%) showed the 16-17b multiexon deletion. All 6 patients had a classical cystic fibrosis phenotype and 5 of the 6 presented with meconium ileus. All patients were alive with supportive care at ages ranging from 8 to 19 years. Sohn et al. (2019) suggested molecular investigation for this deletion mutation in Asian populations including Korea and Japan.</Attribute>
              <Citation>
                <ID Source="PubMed">31136843</ID>
              </Citation>
            </ObservedData>
            <ObservedData>
              <Attribute Type="Description">Wakabayashi-Nakao et al. (2019) reported identification of a deletion of exons 16-17b in CFTR as the most common Japanese cystic fibrosis variant, with frequency of about 70% among Japanese CF patients definitely diagnosed. The pathogenic mutation results in a deletion of 153 amino acids, from glycine at position 970 (G970) to threonine at 1122 (T1122) in the CFTR protein without a frameshift; the authors referred to the mutation as delta-(G970-T1122). The authors characterized this variant in CFTR carrying this deletion in CHO cells using immunoblots and super-resolution microscopy. The protein is synthesized and core-glycosylated but not complex-glycosylated. Lumacaftor (VX-809) could not rescue the maturation defect of the delta-(G970-T1122) protein. Wakabayashi-Nakao et al. (2019) suggested that this mutation should be characterized as a class II variant.</Attribute>
              <Citation>
                <ID Source="PubMed">29951967</ID>
              </Citation>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="CFTR" />
          </GeneList>
          <Name>CFTR, EX16-17b DEL</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">EX16-17b DEL</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="602421.0138" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">CYSTIC FIBROSIS</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="1948046" TraitType="Disease" MappingType="Name" MappingValue="CYSTIC FIBROSIS" MappingRef="Preferred">
        <MedGen CUI="C0010674" Name="Cystic fibrosis" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

